Viewing Study NCT03778593


Ignite Creation Date: 2025-12-25 @ 1:14 AM
Ignite Modification Date: 2026-01-05 @ 5:58 PM
Study NCT ID: NCT03778593
Status: COMPLETED
Last Update Posted: 2021-02-04
First Post: 2018-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: FOLFIRINOX for 2nd-line Treatment of BTC
Sponsor: Dong-A University Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Biliary Tract Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None biliary tract carcinoma View
None 5-FU View
None Irinotecan View
None oxaliplatin View